Enhanced brain function by gaba-ergic stimulation
CA 2413405 A1 · Owner: Leventhal, Audie G. · Inventors: Leventhal, Audie G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods are disclosed for improving age-related decreases in cortical function by increasing the activity of inhibitory pathways such as GABA-ergic , pathways, in the central nervous system. In particular examples subjects with , age-related decreases in cortical function are treated by administering therapeutically effective amounts of a GABA-ergic agonist. The disclosed methods also enable screening for drugs that inhibit an age-related decline in cortical function, for example by exposing a subject to a test agent and , measuring an increase in GABA-ergic cortical inhibitory activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 20, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 20, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 20, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.